Glenmede Trust’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $474K | Sell |
6,653
-13
| -0.2% | -$889 | ﹤0.01% | 982 |
|
|
2025
Q4 | $394K | Buy |
+6,666
| New | +$362K | ﹤0.01% | 1030 |
|
|
2025
Q1 | $255K | Buy |
6,453
+1,085
| +20% | +$48K | ﹤0.01% | 1139 |
|
|
2024
Q4 | $219K | Sell |
5,368
-280,414
| -98% | -$11.7M | ﹤0.01% | 1207 |
|
|
2024
Q3 | $11.1M | Sell |
285,782
-2,855
| -1% | -$114K | 0.05% | 348 |
|
|
2024
Q2 | $12.6M | Buy |
288,637
+2,387
| +0.8% | +$115K | 0.06% | 314 |
|
|
2024
Q1 | $13.7M | Buy |
286,250
+22,650
| +9% | +$1.02M | 0.07% | 303 |
|
|
2023
Q4 | $12.4M | Buy |
263,600
+91,037
| +53% | +$3.78M | 0.06% | 314 |
|
|
2023
Q3 | $8.22M | Buy |
172,563
+3,593
| +2% | +$196K | 0.05% | 362 |
|
|
2023
Q2 | $11.9M | Buy |
168,970
+333
| +0.2% | +$20K | 0.07% | 303 |
|
|
2023
Q1 | $12.1M | Buy |
168,637
+1,996
| +1% | +$158K | 0.07% | 298 |
|
|
2022
Q4 | $11.7M | Sell |
166,641
-20,621
| -11% | -$1.45M | 0.07% | 305 |
|
|
2022
Q3 | $11.4M | Sell |
187,262
-22,668
| -11% | -$1.52M | 0.07% | 291 |
|
|
2022
Q2 | $13.3M | Sell |
209,930
-22,998
| -10% | -$1.5M | 0.08% | 288 |
|
|
2022
Q1 | $14.9M | Sell |
232,928
-1,487
| -0.6% | -$99.5K | 0.07% | 319 |
|
|
2021
Q4 | $16.8M | Sell |
234,415
-2,736
| -1% | -$208K | 0.08% | 287 |
|
|
2021
Q3 | $16.9M | Sell |
237,151
-1,771
| -0.7% | -$140K | 0.09% | 259 |
|
|
2021
Q2 | $19.4M | Sell |
238,922
-465
| -0.2% | -$37.4K | 0.1% | 233 |
|
|
2021
Q1 | $18.1M | Buy |
+239,387
| New | +$17.4M | 0.1% | 233 |
|
|
2020
Q4 | – | Sell |
-1,599
| Closed | -$79K | – | 1867 |
|
|
2020
Q3 | $79K | Sell |
1,599
-5,428
| -77% | -$306K | ﹤0.01% | 1231 |
|
|
2020
Q2 | $369K | Buy |
7,027
+662
| +10% | +$31.4K | ﹤0.01% | 842 |
|
|
2020
Q1 | $556K | Hold |
6,365
| – | – | ﹤0.01% | 873 |
|
|
2019
Q4 | $556K | Sell |
6,365
-1,447
| -19% | -$127K | ﹤0.01% | 873 |
|
|
2019
Q3 | $662 | Buy |
7,812
+932
| +14% | +$83K | ﹤0.01% | 824 |
|
|
2019
Q2 | $723 | Buy |
6,880
+2,014
| +41% | +$202K | ﹤0.01% | 824 |
|
|
2019
Q1 | $513 | Buy |
4,866
+298
| +7% | +$29.9K | ﹤0.01% | 883 |
|
|
2018
Q4 | $381 | Buy |
4,568
+126
| +3% | +$11.4K | ﹤0.01% | 919 |
|
|
2018
Q3 | $452K | Buy |
4,442
+1,260
| +40% | +$122K | ﹤0.01% | 912 |
|
|
2018
Q2 | $258K | Buy |
3,182
+2,024
| +175% | +$161K | ﹤0.01% | 994 |
|
|
2018
Q1 | $81K | Hold |
1,158
| – | – | ﹤0.01% | 1465 |
|
|
2017
Q4 | $81K | Buy |
1,158
+47
| +4% | +$3.39K | ﹤0.01% | 1465 |
|
|
2017
Q3 | $69K | Sell |
1,111
-34
| -3% | -$2.01K | ﹤0.01% | 1528 |
|
|
2017
Q2 | $69K | Hold |
1,145
| – | – | ﹤0.01% | 1489 |
|
|
2017
Q1 | $69K | Buy |
1,145
+27
| +2% | +$1.53K | ﹤0.01% | 1489 |
|
|
2016
Q4 | $60K | Sell |
1,118
-1,021
| -48% | -$49K | ﹤0.01% | 1556 |
|
|
2016
Q3 | $97K | Buy |
2,139
+6
| +0.3% | +$253 | ﹤0.01% | 1407 |
|
|
2016
Q2 | $71K | Buy |
+2,133
| New | +$66.6K | ﹤0.01% | 1453 |
|
Other funds holding NGVT
VPM
VCM
SBH
SCM
Glenmede Trust's NGVT Position: Q1 2026 in Review
Glenmede Trust reduced its Ingevity (NGVT) stake by 0.2% in Q1 2026, selling an estimated $889 and leaving 6,653 shares worth $474K. The position accounts for ﹤0.01% of the portfolio, ranked #982.
Glenmede Trust first reported a position in NGVT in Q2 2016 and has held it in 37 quarters since. The position peaked at $19.4M in Q2 2021. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Glenmede Trust held 6,653 shares of Ingevity worth $474K as of Q1 2026.
- Glenmede Trust sold 13 Ingevity shares in Q1 2026, an estimated $889.
- Ingevity made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #982 holding.
- Glenmede Trust first reported a position in Ingevity in Q2 2016 and has held it in 37 quarters since.
- Glenmede Trust's Ingevity position peaked at $19.4M in Q2 2021.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.